TMCnet News
Global Active Pharmaceutical Ingredient Market Worth $175 Billion by 2020 - Increased Generic Drug Sales & Regional Penetration - Research and MarketsResearch and Markets has announced the addition of the "Active Pharmaceutical Ingredients Global Market - Forecast to 2022" report to their offering. Very few numbers of finished pharmaceutical product manufacturers has their own API manufacturing unit and nobody can make all required APIs in-house. It is basically not easy for API manufacturers in developing countries to ensure a product with quality at a reasonable price. API manufacturing involves conversion of raw materials into API and mixing API and excipients for final formulations. These formulations in the form of tablets, capsules or solutions are packaged and then marketed. Patent expiration of major drugs that increased generic drug sales, government initiatives, increasing aged population and regional penetration, local manufacturer expansion and high uptake of biologics are some of the factors that are driving the market growth. Whereas financial crisis, stringent regulatory policies, less investment in pharmaceutical industry and fragmented market are the factors that are hindering API market growth. North America dominated the lobal API market during the forecast period. Asia Pacific region is the fastest growing with a CAGR of more than 7.5% by 2020 due to patent expirations of drugs, low operation costs, services of Contract Manufacturing Organizations (CMO) and high investments in medical research. Moreover the high cost of skilled labor and energy are the major factors that forced European market to shift their base to countries such as India and China. Companies Mentioned:
Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Global API Market Overview 5 Global API Market, By Therapeutic Application 6 Regional Market Analysis 7 Company Developments 8 Major Player Profile For more information visit http://www.researchandmarkets.com/research/fkcxm8/active View source version on businesswire.com: http://www.businesswire.com/news/home/20160524005860/en/ |
